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Optimization of human, animal, and environmental health by 
using the One Health approach
Jonathan M. Sleeman1,*, Thomas DeLiberto2, Natalie Nguyen1
1USGS National Wildlife Health Center, Madison, WI 53711, USA
2USDA APHIS Wildlife Services, National Wildlife Research Center, Fort Collins, CO 80521-2154, USA
Emerging diseases are increasing burdens on public health, negatively affecting the world economy, causing extinction of species, and 
disrupting ecological integrity. One Health recognizes that human, domestic animal, and wildlife health are interconnected within ecosystem 
health and provides a framework for the development of multidisciplinary solutions to global health challenges. To date, most 
health-promoting interventions have focused largely on single-sector outcomes. For example, risk for transmission of zoonotic pathogens 
from bush-meat hunting is primarily focused on human hygiene and personal protection. However, bush-meat hunting is a complex issue 
promoting the need for holistic strategies to reduce transmission of zoonotic disease while addressing food security and wildlife conservation 
issues. Temporal and spatial separation of humans and wildlife, risk communication, and other preventative strategies should allow wildlife 
and humans to co-exist. Upstream surveillance, vaccination, and other tools to prevent pathogen spillover are also needed. Clear multi-sector 
outcomes should be defined, and a systems-based approach is needed to develop interventions that reduce risks and balance the needs of 
humans, wildlife, and the environment. The ultimate goal is long-term action to reduce forces driving emerging diseases and provide 
interdisciplinary scientific approaches to management of risks, thereby achieving optimal outcomes for human, animal, and environmental 
health.
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Introduction: Why One Health?
Emerging infectious diseases, defined as novel or known 
infectious diseases increasing in incidence within a specific 
location or population, and environmental contaminants pose 
global and profound threats to human, animal, and 
environmental health [17,32,39]. The rise of emerging 
infectious diseases demonstrates the dynamic relationship 
among pathogens, hosts, and their environment [20,32,39]. 
Over sixty percent of emerging infectious diseases are zoonotic, 
and over seventy percent of those zoonoses have a wildlife 
origin [20], including highly pathogenic avian influenza 
(HPAI), sylvatic plague, Lyme disease, anthrax, and severe 
acute respiratory syndrome (SARS). These diseases increase 
burdens on public health systems, negatively impact the world 
economy, cause declines and extinctions of animal species, and 
increase loss of ecological integrity [8,23]. The potential global 
impact of a wildlife-associated pathogen on human health is 
exemplified by the over 35 million people currently infected 
with human immunodeficiency virus (HIV), which is reported 
to have originated from a simian (primate) virus [13]. Likewise, 
negative effects of emerging and resurging diseases on 
agriculture, food safety and security, wildlife health, and human 
health in Southeast Asia have resulted from outbreaks of HPAI 
[16,29,40]. There are also several newly described pathogens 
and diseases that have resulted in wildlife population declines 
and global extinctions. Batrachochytrium dendrobatidis, a 
cutaneous fungal infection of amphibians, is linked to global 
declines of amphibian populations [22], and Pseudogymnoascus 
destructans, the etiologic agent of white-nose syndrome, has 
caused precipitous declines in the abundance of North 
American hibernating bat species [3]. Such large-scale losses of 
animal species and biodiversity subsequently jeopardize the 
ecosystems on which all life depends [7,18]. Of particular 
concern are novel emerging infectious diseases of wildlife 
origin as they are difficult to anticipate, devastating to wildlife 
populations, challenging to manage, and have the potential to 
have ecological ripple effects. Emerging diseases and 
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Fig. 1. Diagram illustrating the concept of One Health; that is, the
connection of human, domestic animal, and wildlife health 
within the context of ecosystem health. Figure designed by John
M. Evans, USGS. 
pathogens of wildlife origin are increasing globally at alarming 
rates, in both incidence and by geographic location, which can 
be largely attributed to the driving forces of globalization, an 
increasing human population, and climate change [8,20,23,48].
Globalization, including the rising amounts of international 
human travel and trade in animal- and plant-based products and 
other goods, potentiates the spread of pathogens 
[21,23,24,35,49,51]. Emerging infectious diseases are also 
driven by socio-economic, environmental, and ecological 
factors, including ecological disruption, microbial adaptation, 
and lack of preventative measures [6,8]. For example, 
outbreaks of HPAI in Southeast Asia present ongoing 
challenges to biosecurity and food safety related to trade, 
transport, and marketing of poultry within and between 
countries [11,46]. The growing human population and the 
ensuing urban development increase interactions among 
people, domestic animals, and wildlife, further escalating the 
risk for transmitting pathogens and initiating novel disease 
outbreaks [5,14,23,50]. Climate change can also facilitate the 
movement of pathogens into new geographic regions [34,42]. 
Additionally, climate change is altering insect population 
dynamics and increasing the potential for spread of vector- 
borne diseases, which constitute twenty to thirty percent of all 
emerging infectious diseases [15,20,36].
As a demonstration of an interconnected system, bats 
contribute up to 50 billion USD annually to the United States of 
America (US) agricultural economy through their part in insect 
control [4]. However, the emergence of white-nose syndrome 
has resulted in the death of over 6 million bats in North America 
resulting in a marked decrease in insect control [3]. 
Additionally, while bats are critical components of world 
ecosystems, they are also potential reservoirs of zoonotic 
viruses, including rabies, Marburg virus, and Nipah virus [27]. 
In today’s age of dynamic changes in the emergence of 
infectious diseases associated with increasing interactions 
among humans, domestic animals, and wildlife, the need to 
consider these interactions fully becomes crucial for effective 
management that balances the needs of humans, animals, and 
the environment.
Such issues are not limited to infectious diseases. For 
example, while it has long been known that human exposure to 
unsafe levels of methylmercury is predominantly through 
dietary consumption of contaminated fish and shellfish, recent 
technological advances in high-resolution mass spectroscopy 
now provide a means to “fingerprint” the contributing mercury 
and determine its source [26]. For example, many locations are 
impacted by both point-source releases as well as nearly 
ubiquitous atmospheric fallout of mercury. This new fingerprinting 
capability has extended the capacity to determine which 
mercury sources contribute to fish, wildlife, and human 
exposures, thereby informing environmental decision makers 
of the most effective means to reduce such exposures.
What Is One Health?
The concept of One Health, defined as the collaborative effort 
of multiple disciplines—working locally, nationally, and 
globally—to attain optimal health for people, animals, and the 
environment, has been receiving growing recognition (One 
Health Commission, USA; Fig. 1). One Health acknowledges 
that human, domestic animal, and wildlife health are 
interconnected within the context of ecosystem health and 
provides a useful conceptual framework for the development of 
solutions to global health challenges. To date, most 
health-promoting interventions have focused largely on 
single-sector outcomes. By using the One Health concept as a 
framework, disease management and regulatory strategies can 
optimize outcomes for humans, animals, and the environment. 
For example, risk for transmission of zoonotic pathogens from 
wildlife to bush-meat hunters and other consumers of bush-meat 
is regarded as a public health issue, and current interventions 
focus primarily on educating bush-meat hunters about hygiene 
and personal protection (United States Agency for International 
Development [USAID], USA). However, bush-meat hunting is 
a complex issue with environmental and food security 
consequences if conducted unsustainably; thus, the need to 
support holistic strategies to reduce transmission of zoonotic 
disease while simultaneously ensuring food security and 
safeguarding wildlife populations.
Opportunities for a One Health Approach
Emerging infectious diseases have non-random global 
patterns of emergence [20], and development of the ability to 
appropriately predict, detect, and respond to emerging 
infectious diseases is crucial in preventing the spread of such 
diseases. Opportunities to implement a One Health approach 
are enhanced by the availability of new technologies and 
methodologies, including surveillance tools, diagnostics, and 
vaccines that have been developed through applied research 
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Fig. 2. Hypothetical example of how detection of pathogens or 
diseases in wildlife prior to the detection of cases in domestic 
animals and humans can provide an early detection, rapid 
response system for the agriculture and public health sectors. 
[32]. For example, the development of new laboratory 
technologies and computational methods has facilitated major 
advances in our ability to detect and characterize emerging 
contaminants and pathogens and to define disease risks. 
Specifically, advances in molecular biology have opened new 
avenues for the identification and detection of pathogens [47], 
and spatially referenced database applications allow for risk 
assessments that can assist in spatial and temporal targeted 
disease surveillance in accordance with anticipated disease 
threats. However, just as health interventions are often 
single-sector focused, disease surveillance systems may be 
equally limited. There are instances of major threats to human 
or domestic animal health that were unrecognized due to the 
lack of integration of environmental, wildlife, domestic animal, 
and public heath surveillance data [43]. For example, there were 
delays in recognizing that human cases of encephalitis and 
concurrent mortalities of crows in New York, United States in 
1999 shared the West Nile virus as a common etiology due to the 
absence of an established communication protocol between the 
public health and wildlife health sectors [31]. Additionally, 
there is often insufficient surveillance in wildlife populations, 
thereby delaying the identification of and response to a disease 
event, consequently resulting in increased negative effects on 
wildlife and domestic animals. For example, a recent outbreak 
of Peste de Petits Ruminants in saiga antelope (Saiga tatarica 
mongolica) from Mongolia went unrecognized for several 
months, resulting in loss of approximately 50% of the population 
(Food and Agriculture Organization of the United Nations 
[FAO], Italy). Surveillance in wildlife populations not only can 
protect wildlife from disease but also can provide early 
detection and rapid responses to domestic animal and public 
health threats, as a consequence of upstream surveillance (Fig. 
2).
In addition, epidemiological studies to determine disease 
causation allow the development of interventions based on 
temporal and spatial separation of humans, domestic animals, 
and wildlife, as well as other preventive measures. Risk 
communication to modify human behaviors, along with other 
disease management strategies, are also needed to prevent 
disease transmission and allow wildlife and humans to co-exist 
in the same environment [14]. Finally, development of specific 
disease-management tools or interventions should follow a One 
Health approach. For example, oral vaccination of wildlife for 
rabies control has been important in minimizing exposure of 
domestic animals and humans to the deadly virus [37,45]. In 
another developing example, an orally ingestible vaccine is 
being used to prevent sylvatic plague in prairie dogs and 
sympatric endangered black-footed ferrets to conserve both 
wildlife populations and protect human health [1]. By 
implementing a One Health approach, such holistic strategies 
should become more common in promoting global health and 
ecological sustainability.
One Health in Action
The US government response to HPAI in wild and domestic 
birds is an example of One Health in action. In the late fall of 
2014, the US experienced an unprecedented introduction of a 
Eurasian strain of the HPAI virus [25]. This virus, termed HPAI 
H5N8, was likely introduced by wild waterfowl during their 
normal migratory movements between Asia and North 
America. Once introduced, the HPAI H5N8 virus quickly 
spread along the Pacific Flyway of the US, and began mixing 
with the low pathogenic, native North American avian 
influenza viruses, resulting in the creation of two novel HPAI 
viruses. One of these novel viruses, termed HPAI H5N2, spread 
to the Central and Mississippi Flyways in the US Midwest in 
winter and spring of 2015. Collectively, these HPAI viruses 
were responsible for the costliest animal disease emergency 
event ever documented in the US, resulting in a loss of over four 
billion USD to the American agriculture industry and the US 
economy [12,41].
In response to the HPAI virus introduction, the Interagency 
Steering Committee for Avian Influenza Surveillance in Wild 
Migratory Birds (Interagency Steering Committee), comprised 
of state and federal scientists from the US Departments of 
Agriculture, the Interior, and Health and Human Services, and 
state natural resources agencies, coordinated state and federal 
scientists in the development and implementation of an 
enhanced surveillance system for the Pacific Flyway [2]. By the 
end of January 2015, only six weeks after the initial HPAI 
detection, over 4,000 wild birds were sampled and tested, 
effectively documenting the role of specific species of wild 
ducks as reservoirs for the viruses, the particular sensitivity to 
infection of raptor species resulting in morbidity and mortality, 
the distribution of the HPAI H5N8 virus throughout the Pacific 
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Flyway with limited spread of the HPAI H5N2 form, and, by 
using genetic sequence analysis, confirming that the viruses had 
not yet developed the capacity to infect mammals, including 
humans.
Unfortunately, by March and April of 2015, new infection 
foci were established in the US Midwest. Once again, federal 
and state wildlife disease experts were mobilized to investigate 
the role wildlife species were playing in these new outbreaks 
and to assist in determining how the viruses might be moving 
among farms and the environment. Additionally, the 
Interagency Steering Committee identified a working group of 
federal and state wildlife and agricultural ecologists, 
veterinarians, biologists, epidemiologists, and statisticians, 
which was assigned to develop a National Surveillance Plan 
that would identify the distribution of the HPAI viruses in wild 
birds throughout the US [19]. This group relied heavily on 
knowledge gained from the previous surveillance program as 
well as using information from ongoing research into avian 
influenza in wild birds.
In July 2015, the Interagency Steering Committee led the 
implementation of the US National Surveillance Plan for 
Highly Pathogenic Avian Influenzas in Wild Birds [19]. 
Through that plan, over 77,000 wild birds were successfully 
tested for HPAI by January 2017, thereby documenting a 
persistent circulation of HPAI H5N2. The success of this 
program indicates how interagency collaborations can 
effectively and efficiently protect US agriculture, natural 
resources, and human health and safety. For example, the wild 
bird surveillance program has effectively provided early 
warnings to the poultry industry, agricultural officials, wildlife 
agencies, conservation programs, wildlife rehabilitators, zoos, 
and public health officials regarding the potential introduction 
and emergence of HPAI viruses. The program has also 
improved on-farm biosecurity measures by providing enhanced 
biosecurity recommendations to the poultry industry [44]. 
These recommendations were primarily developed through 
recognition of the risks of creating habitat for wildlife near 
poultry production facilities that would inadvertently provide 
food, water, and shelter to wild birds and mammals. The 
recommendations also sought to modify and enhance 
management practices on farms to prevent transmission by the 
movement of people, feed, equipment, and waste products.
The US surveillance program for HPAI in wild birds is also 
seen as a model of One Health collaboration through its 
communication and outreach efforts to stakeholders and the 
public. The Interagency Steering Committee and its member 
agencies have produced numerous fact sheets, frequently asked 
questions, webinars, presentations, and web pages to keep 
scientists, policy makers, industry, and the public up-to-date on 
the global status of avian influenza and the US HPAI 
surveillance program, on how producers can minimize the risk 
of transmission to poultry, and on how hunters and poultry 
workers can minimize the risk of acquiring diseases from 
handling birds.
The One Health approach toward detecting and managing 
avian influenzas in the US has been successful because of 
several factors, the primary one being effective collaboration. 
Through identification of a clear purpose and vision, 
establishment of a governance structure, and by setting 
achievable goals, the Interagency Steering Committee was able 
to rapidly develop national surveillance strategies and plans. 
This could not have been possible without policy-level support, 
which facilitated the commitment of participating agencies to 
work together on avian influenzas over the last 14 years [9]. 
Policy-level support has been identified as a key component of 
successful collaborations in One Health programs [6,10,30,33]. 
Successful collaborations are also fostered through active 
communication among partners, information exchange within 
and across agencies, policy makers, and the public, as well as 
with the participation of stakeholders. For example, the public 
is encouraged to report sick and dead birds to wildlife officials, 
most apparently healthy wild bird samples are obtained from 
hunter-harvested birds, and there is active surveillance on farms 
during outbreaks.
Another, and perhaps most important, factor in the success of 
the One Health approach in detecting and managing avian 
influenzas in the US is the presence of advocates who were 
dedicated and committed to the cause, even when that cause was 
not their primary job focus. In this case, it is the members of the 
Interagency Steering Committee, many of who have been 
committee participants for over 10 years. Similarly, a review of 
several interagency One Health projects revealed that certain 
common factors, including group and individual leadership 
skills, were essential to the success of the projects [38]. 
However, while progress has been made toward integration of 
disciplines, some segregation remains, as was illustrated by a 
recent study that showed that sectors continue to differ in the 
systems studied, questions asked, and methods employed [28].
Conclusions
The One Health concept is important in the development of 
interventions and actions that optimize outcomes for human, 
animal, and environmental health. The growing challenges 
presented by globalization, climate change, environmental 
contamination, human population growth, agricultural and 
urban development, and degraded ecological integrity pose 
substantial risks to global health, food security, and ecological 
sustainability, especially through the spread of emerging and 
zoonotic diseases. With the multitude of influencing factors, not 
only will occurrences of emerging infectious diseases persist, 
but the rate at which emerging infectious diseases are observed 
will also increase [6]. Improved regulatory frameworks and 
holistic management strategies are needed to mitigate these 
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emerging threats. To guide this response, clear multi-sector 
outcomes need to be defined. Understanding the epidemiology 
of relevant diseases, the unique challenges presented by each 
disease, and the current strategies used in the management of 
applicable diseases is needed to undertake properly informed 
decision-making and to support a One Health, systems-based 
approach to the development of interventions that will reduce 
risks and balance needs of humans, animals, and the 
environment. The ultimate goal will be to focus on long-term 
action directed at reducing the factors driving emerging 
diseases and contaminants and to provide interdisciplinary 
scientific approaches to manage environmental contaminants 
and emerging, high-consequence disease risks in order to 
achieve optimal outcomes for human, animal, and 
environmental health.
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